GENova names Aaron Whiteman as CEO( and general economic market or business...),Health
Navigation Links
GENova names Aaron Whiteman as CEO
Date:8/18/2009
, and general economic market or business conditions.
'/>"/>
| SOURCE GENova Biotherapeutics, Inc. Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
2. Mediware Names Thomas K. Mann Chief Executive Officer
3. Cleveland-based Health Care Tech Company Within3 Names New CEO
4. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
5. Patient Safety Authority Board of Directors Names Infection Advisory Panel
6. Hooper Holmes Names Chris Behling President of Health & Wellness Division
7. MDMA Names New Director of Federal Affairs
8. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
9. Acuo Technologies(R) Names Mike Dolan Vice President of Sales
10. MAKO Surgical Corp. Names Frederic H. Moll, M.D. to Board of Directors
11. Arthur M. Blank Family Foundation Names Susan Bertonaschi Program Officer, Better Beginnings
Post Your Comments:
Breaking Medicine News(10 mins):Health News:pcRUSH.com / Atman, Inc. is Awarded General Services Administration (GSA) Schedule (GS-35F-0099W) 2Health News:Pathological Gambling May Be Successfully Treated With Medications for Substance Addiction 2Health News:University of Utah Announces New Studies on the Benefits of Treadmill Desks 2Health News:University of Utah Announces New Studies on the Benefits of Treadmill Desks 3Health News:Nonprofit Partners With PR Company and Gains International Attention 2Health News:Bishops Deeply Disappointed by Senate Vote to Table Nelson-Hatch-Casey Amendment 2
[0] pcRUSH.com / Atman, Inc. is Awarded General Services Administration (GSA) Schedule (GS-35F-0099W)[0] Pathological Gambling May Be Successfully Treated With Medications for Substance Addiction[0] University of Utah Announces New Studies on the Benefits of Treadmill Desks[0] Nonprofit Partners With PR Company and Gains International Attention[1] Bishops Deeply Disappointed by Senate Vote to Table Nelson-Hatch-Casey Amendment
Other Medicine News:Health News:MEDRAD Sponsors PET Research with University of Zurich 2Health News:MEDRAD Sponsors PET Research with University of Zurich 3Health News:MEDRAD Sponsors PET Research with University of Zurich 4Health News:Kawasaki Disease Treated with Plasma-Derived Therapy 2Health News:ITelagen Develops Customized Health Advocacy System for Wellness 360 2Health News:ITelagen Develops Customized Health Advocacy System for Wellness 360 3Health News:ITelagen Develops Customized Health Advocacy System for Wellness 360 4Health News:Anthem Blue Cross and Blue Shield Introduces SmartSense, Price-Conscious Plans Targeted at the Uninsured 2Health News:Minnesota Dentists Announce Plans to Provide Free Dental Care to Needy Children in Minnesota 2
MEDRAD Sponsors PET Research with University of ZurichKawasaki Disease Treated with Plasma-Derived TherapyITelagen Develops Customized Health Advocacy System for Wellness 360Family History of Aneurism Raises Stroke Risk for SmokersAnthem Blue Cross and Blue Shield Introduces SmartSense, Price-Conscious Plans Targeted at the UninsuredMinnesota Dentists Announce Plans to Provide Free Dental Care to Needy Children in Minnesota
Breaking Medicine Technology:ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 2ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 3Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 3Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 3More Evidence Healthy Living Brings Long Life 54102 1More Evidence Healthy Living Brings Long Life 54102 2More Evidence Healthy Living Brings Long Life 54102 3The Elephant in the Room 3A Panel on Immigrations Impact on Health Care Reform 54098 1AnimalScan LLC Acquires Iams Pet Imaging LLC 54094 1AnimalScan LLC Acquires Iams Pet Imaging LLC 54094 2
[0] ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference[0] Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock[0] Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix
Other Medicine Technology:Clinical Trial Results Suggest Long-Term Treatment Benefit of,Tetrabenazine for Chorea Associated with Huntington's Disease 2Clinical Trial Results Suggest Long-Term Treatment Benefit of,Tetrabenazine for Chorea Associated with Huntington's Disease 3Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 2Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 3Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 4Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 5
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |